Inhalant nitrite use in bipolar affective disorder

Australian and New Zealand Journal of Psychiatry

Volumn 43, Issue 10, 2009, Pages 980-981

  Nathan, Ravindran ^a   Bastiampillai, Tarun ^a   Naveen, Magadi N ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRATE; ATYPICAL ANTIPSYCHOTIC AGENT; BUTYL NITRITE; LITHIUM; NITRIC OXIDE; VALPROIC ACID;

ADULT; ANAMNESIS; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG INDUCED DISEASE; HUMAN; INHALANT ABUSE; LETTER; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY;

EID: 71049126888     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670903179251     Document Type: Letter

References (6)

1. National Inhalant Abuse Taskforce. National directions in inhalant abuse. Melbourne: Victorian Government Department of Human Services, 2006.
2. Newell GR, Spitz MR,Wilson MB. Nitrite inhalants: historical perspective. NIDA Res Monogr 1988; 83:1-14.
3. Williams JF, Storck M, Committee on Substance Abuse and Committee on Native American Child Health. Inhalant abuse. Paediatrics 2007; 119:1009-1017.
4. Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 2004; 18:377-390.
5. Andreazza AC, Kauer-Sant'Anna M, Frey BN et al. Oxidative stress in bipolar disorder: a meta-analysis. J Affect Disord 2008; 111:135-144.
6. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitritenitric oxide pathway in physiology and therapeutics. Nature 2008; 7:156-167.